EU Member States will now conduct health technology assessments (HTAs), which are analyses to monitor the long-term properties and effects of medicines, devices, procedures, and medical acts. Negotiators from the Council of the EU and the European Parliament reached agreement on Tuesday 22 June on a draft regulation in this regard (see EUROPE B11951A6).
The text will enter into force after final approval by the EU27 ambassadors and all MEPs. It will then apply from 2024 onwards, and...